Jane Street Group, LLC Aclaris Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 82,727 shares of ACRS stock, worth $239,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,727
Previous 335,009 75.31%
Holding current value
$239,081
Previous $368,000 74.73%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.12 - $1.4 $282,555 - $353,194
-252,282 Reduced 75.31%
82,727 $93,000
Q2 2024

Aug 14, 2024
BUY
$1.01 - $1.36 $3,301 - $4,445
3,269 Added 0.99%
335,009 $368,000
Q1 2024

May 15, 2024
BUY
$0.92 - $1.44 $66,567 - $104,192
72,356 Added 27.9%
331,740 $411,000
Q4 2023

Feb 14, 2024
BUY
$0.64 - $6.49 $61,007 - $618,652
95,324 Added 58.1%
259,384 $272,000
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $85,444 - $142,623
13,025 Added 8.62%
164,060 $1.12 Million
Q2 2023

Aug 14, 2023
SELL
$7.89 - $10.64 $208,501 - $281,172
-26,426 Reduced 14.89%
151,035 $1.57 Million
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $1.25 Million - $3.19 Million
177,461 New
177,461 $1.44 Million
Q4 2021

Feb 15, 2022
SELL
$12.27 - $18.49 $116,466 - $175,507
-9,492 Reduced 23.31%
31,228 $454,000
Q3 2021

Nov 16, 2021
BUY
$13.38 - $18.8 $219,672 - $308,658
16,418 Added 67.56%
40,720 $733,000
Q1 2021

May 18, 2021
BUY
$5.86 - $27.73 $67,981 - $321,695
11,601 Added 91.34%
24,302 $612,000
Q4 2020

Feb 17, 2021
SELL
$2.65 - $7.61 $44,443 - $127,627
-16,771 Reduced 56.9%
12,701 $82,000
Q3 2020

Nov 17, 2020
SELL
$1.5 - $2.71 $259,066 - $468,046
-172,711 Reduced 85.42%
29,472 $76,000
Q2 2020

Aug 17, 2020
BUY
$1.04 - $1.73 $210,270 - $349,776
202,183 New
202,183 $328,000
Q4 2019

Feb 14, 2020
SELL
$1.02 - $1.97 $14,765 - $28,517
-14,476 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$0.79 - $2.47 $13,486 - $42,165
-17,071 Reduced 54.11%
14,476 $16,000
Q2 2019

Aug 15, 2019
BUY
$2.13 - $7.06 $67,195 - $222,721
31,547 New
31,547 $69,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email